Low ceiling temperature poly(aldehyde) microcapsules for payload delivery
Innovative microcapsules with a cyclic polyphthalaldehyde (cPPA) shell offer controlled payload release upon exposure to sunlight or heat. These biodegradable microcapsules can revolutionize drug delivery, agriculture, and more, with an emphasis on environmentally friendly applications.
Overview
The development of low ceiling temperature poly(aldehyde) microcapsules presents a groundbreaking approach to controlled payload delivery. These microcapsules, with a cyclic polyphthalaldehyde (cPPA) shell, utilize a photo-triggerable mechanism for releasing their core content. By incorporating a photoacid generator (PAG), the cPPA shell can be activated by sunlight or thermal exposure, leading to depolymerization and release of the encapsulated payload. This technology holds potential for various applications, including drug delivery systems, agricultural treatments, and environmentally friendly material decomposition.
Technical specifications
The microcapsules are fabricated using an emulsification process, resulting in uniform spherical structures. The cPPA shell is designed with a high molecular weight (197 kDa), providing stability and controlled degradation. The core is significantly larger than the shell, with a diameter 28.5 times greater. Upon a 30-second ultraviolet exposure, approximately 85% of the payload is released, demonstrating the efficiency of the photo-triggerable mechanism. Although the bio-degradation rate is yet to be measured, the cyclic polymers degrade instantly upon bond disruption, making them highly susceptible to chemical stimuli.
Technology readiness level
Currently at Technology Readiness Level 4, this technology has been validated in laboratory settings with plans for further optimization and environmental testing. Future work includes refining microcapsule synthesis to meet specific size and volume requirements, evaluating the environmental lifetime, and assessing the bio-activity and acidity of the materials.
About Georgia Institute of Technology
Georgia Institute of Technology is a large, technology‑focused public research university in Atlanta with a strong applied research culture. Industry engages through the Georgia Tech Research Institute for contract R&D, a Midtown innovation district with co‑located corporate labs, and a statewide manufacturing extension to support scale‑up. A long‑standing partnership with a major academic medical center enables clinical translation, and a large co‑op program delivers a steady talent pipeline. Research is backed by competitive federal funding from NSF, NIH, DOE, DoD, and NASA. Technology commercialization is managed by the Georgia Tech Research Corporation, with dedicated licensing, corporate contracting, and startup support.
delivered to your inbox.